British pharmaceutical giant AstraZeneca has secured NHS approval for its groundbreaking breast cancer drug capivasertib, marking a significant milestone in oncology treatment. The twice-daily tablet, developed in Cambridge, demonstrates remarkable
Pharmaceutical8- Page
196Articles
Revolutionary NHS Cancer Vaccine Trial Signals Fresh Hope for Investment in UK Healthcare Innovation
The National Health Service has unveiled a groundbreaking initiative, offering accelerated access to a pioneering cancer vaccine trial. This strategic move demonstrates the UK’s commitment to maintaining its position at
UK Government Accelerates Clinical Trials and Improves Access to NHS Data The United Kingdom government has unveiled ambitious plans aimed at enhancing the speed of clinical trials and facilitating greater
Keir Starmer has announced a series of significant measures aimed at bolstering the car and pharmaceutical sectors as the UK grapples with a shifting global landscape following Donald Trump’s imposition
Almost £8 billion has been erased from the value of the world’s largest pharmaceutical companies following the unexpected ousting of America’s leading vaccine authority by Robert F Kennedy Jr. Shares
Britain’s largest pharmaceutical company, AstraZeneca, has revealed plans to invest $2.5 billion in Beijing, signalling its commitment to expanding operations in its second-largest market despite ongoing controversies. The announcement showcases
A pioneering pharmaceutical breakthrough is set to give dog owners more precious time with their companions as Loyal, a San Francisco-based biotech company, prepares to launch the world’s first dog
Britain’s largest pharmaceutical companies have raised urgent concerns over what they describe as an “excessive” NHS sales rebate, warning it is harming investment in an economically crucial sector. Industry leaders
AstraZeneca, one of the world’s leading pharmaceutical companies, has announced a transformative acquisition of the Belgium-based biotech firm Esobiotec in a deal worth up to $1 billion. This strategic move
The Swiss pharmaceutical giant Roche has announced a partnership with Danish biotechnology firm Zealand Pharma in a deal valued at up to $5.3 billion. The collaboration aims to develop and
Swiss pharmaceutical giant Roche has finalised a £4.4 billion deal with Danish biotech firm Zealand Pharma to develop and commercialise a next-generation obesity treatment. The agreement focuses on Petrelintide, a
The activist investor DBay Advisors is set to take Alliance Pharma private with a final, sweetened offer of £362 million. The Isle of Man-based investment firm has increased its cash
In an unprecedented shift within the underground pharmaceutical market, drug dealers across the UK are diversifying their offerings to include sought-after weight-loss medications alongside traditional illicit substances. The weight-loss injection
British online pharmacies have witnessed extraordinary growth, with some providers reporting up to 300% increase in demand, primarily driven by the surging popularity of weight-loss medications. Market analysis from SpendMapper
Recent clinical trials have unveiled a significant breakthrough in the potential application of weight-loss medication Semaglutide, marketed as Wegovy, in reducing alcohol consumption. The groundbreaking study demonstrated a remarkable 40%
Chancellor Rachel Reeves recently visited Siemens Healthineers in Oxford to present a vision for revitalising Britain’s economic growth. Highlighting the nation’s potential in areas such as artificial intelligence and life
